»ó´Ü¿©¹é
±â»ç (Àüü 26°Ç)
[Cover Story] ¼¼°è¿Í ±³·ùÇÏ°í ´ëÁß ¼ÓÀ¸·Î...¡°ÇÐȸ ¸ðµç ¿ª·® µ¿¿øÇØ Ç÷¾Ð Á¶Àý·ü 10% ´õ ²ø¾î ¿Ã¸± °Í¡±  ÀÌ»óµ· ±âÀÚ 2018-11-08 16:46
[Sub Story] Çѱ¹ÀÎ °íÇ÷¾ÐÀÇ ¿ªÇÐ: À¯º´¡¤ÀÎÁö¡¤Ä¡·á¡¤Á¶Àý·ü°ú Ç×°íÇ÷¾ÐÁ¦ Ä¡·áÇöȲ THE MOST 2018-11-08 16:40
[Sub Story] ´ëÇÑ°íÇ÷¾ÐÇÐȸ 2018 °íÇ÷¾Ð Áø·áÁöħ             THE MOST 2018-11-08 16:34
[Sub Story] 2017 ¹Ì±¹½ÉÀåÇÐȸ¡¤½ÉÀåÇùȸ °íÇ÷¾Ð °¡À̵å¶óÀÎ THE MOST 2018-11-08 16:26
[Sub Story] 2018 À¯·´½ÉÀåÇÐȸ¡¤°íÇ÷¾ÐÇÐȸ °íÇ÷¾Ð °ü¸® °¡À̵å¶óÀÎ THE MOST 2018-11-08 16:12
¶óÀÎ
[Sub Story] °¡¸é¡¤¹éÀÇ°íÇ÷¾Ð: °¡Á¤Ç÷¾Ð°ú 24½Ã°£È°µ¿Ç÷¾ÐÀÇ ÀÓ»óÀû È¿¿ë¼º THE MOST 2018-11-08 15:52
[Sub Story] SPRINT ¿¬±¸ ÅëÇØ º» ¿ø³»¡¤Áø·á½Ç Ç÷¾ÐÃøÁ¤¹ýÀÇ ÇöÀç¿Í ¹Ì·¡ THE MOST 2018-11-08 15:47
[Sub Story] Ç×°íÇ÷¾ÐÁ¦ Ä¡·á½ÃÀÛ ½ÃÁ¡°ú Ç÷¾Ð ¸ñǥġ THE MOST 2018-11-08 14:49
[Sub Story] Ç×°íÇ÷¾ÐÁ¦ 1Â÷Ä¡·á: º£Å¸Â÷´ÜÁ¦ THE MOST 2018-11-08 14:44
[Sub Story] Ç×°íÇ÷¾ÐÁ¦ 1Â÷Ä¡·á: RAAS ¾ïÁ¦Á¦ THE MOST 2018-11-08 14:29
¶óÀÎ
[Sub Story] Ç×°íÇ÷¾ÐÁ¦ 1Â÷Ä¡·á: Ä®½·±æÇ×Á¦ THE MOST 2018-11-08 14:23
[Sub Story] Ç×°íÇ÷¾ÐÁ¦ 1Â÷Ä¡·á: ÀÌ´¢Á¦ THE MOST 2018-11-08 14:16
[Sub Story] ´ç´¢º´ ȯÀÚÀÇ Ç÷¾ÐÄ¡·á THE MOST 2018-11-08 14:10
[Sub Story] ½ÅÀåÁúȯ ȯÀÚ¿¡¼­ Ç÷¾ÐÄ¡·á THE MOST 2018-11-08 14:02
[Sub Story] ³ëÀÎ °íÇ÷¾ÐÀÇ Ä¡·á THE MOST 2018-11-08 13:58
¶óÀÎ
[Interview] Ç÷¾Ð°ü¸® À̲ø¾î¿Â 24³â ±â¹ÝÀ¸·Î, ¡®2025³â CVD 25%¡é¡¯ À§ÇØ ´Þ¸°´Ù ÀÓ¼¼Çü ±âÀÚ 2018-11-08 13:50
[Drug Review] Àû±ØÀû Ç÷¾ÐÁ¶Àý Æз¯´ÙÀÓ ¼Ó ºÎ°¢µÇ´Â 3Á¦ º¹ÇÕÁ¦ ÀÓ¼¼Çü ±âÀÚ 2018-11-08 13:43
[Drug Review] ½Ã³×Ãò¶ó, ±â°üÁö Áõ»ó°ü¸® ³Ñ¾î Ç×¹ÙÀÌ·¯½º È¿°ú¿¡µµ ÁÖ¸ñ ÀÓ¼¼Çü ±âÀÚ 2018-11-08 13:36
[Expert Opinion] ¸¸¼ºÄáÆϺ´ ȯÀÚ¿¡¼­ ASCVD À§Çè°ü¸®: ARB/Statin ´ÜÀϺ¹ÇÕÁ¦ÀÇ ¿ªÇÒ ÆíÁýºÎ 2018-11-08 13:31
[Conference Report] ±âÀü ´Ù¸¥ °­·Â¡¤Áö¼Ó Ç÷¾Ð°­ÇÏÁ¦ Çϳª·Î ¹¶Ä¡¸é ÀÌ»óµ· ±âÀÚ 2018-11-08 13:24
Back to Top